EMEA-000431-PIP01-08-M11

Table of contents

Key facts

Invented name
  • Relvar Ellipta
  • Relvar Ellipta and associated names
Active substance
  • vilanterol
  • fluticasone furoate
Therapeutic area
Pneumology-allergology
Decision number
P/0374/2020
PIP number
EMEA-000431-PIP01-08-M11
Pharmaceutical form(s)
Inhalation powder, pre-dispensed
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Inhalation use
Contact for public enquiries
Glaxo Group Limited

E-mail: eu.paediatrics-plans@gsk.com
Tel. +1 4388998201

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating